Stephen W. Potter - 17 Jun 2021 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP

Role
Chief Business Officer
Signature
/s/ Stacie Aarestad, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 18:26:06 UTC
Next filing
29 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGTC Common Stock Award $0 +35,000 +101% $0.000000 69,677 17 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Applied Genetic Technologies Corporation ("AGTC") 2013 Equity and Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of AGTC common stock. The RSUs vest in two installments, with 75% vesting on June 30, 2022 and the remaining 25% vesting on December 31, 2022, subject to the Reporting Person's continued employment with or performance of services for the Company as of each vesting date.

Remarks:

Exhibit 24 Power of Attorney filed herewith.